AMPOLLINI, Luca
 Distribuzione geografica
Continente #
EU - Europa 12.016
NA - Nord America 11.154
AS - Asia 9.473
SA - Sud America 1.227
AF - Africa 470
Continente sconosciuto - Info sul continente non disponibili 349
OC - Oceania 8
Totale 34.697
Nazione #
US - Stati Uniti d'America 10.888
IT - Italia 6.497
SG - Singapore 3.342
CN - Cina 2.609
VN - Vietnam 1.289
IE - Irlanda 1.074
BR - Brasile 942
SE - Svezia 814
FR - Francia 806
FI - Finlandia 766
HK - Hong Kong 744
DE - Germania 522
BD - Bangladesh 441
NL - Olanda 440
ZA - Sudafrica 345
TR - Turchia 305
UA - Ucraina 283
GB - Regno Unito 239
IN - India 185
CA - Canada 137
AR - Argentina 117
RU - Federazione Russa 110
AT - Austria 86
ES - Italia 73
MX - Messico 73
IQ - Iraq 69
BE - Belgio 60
JP - Giappone 53
PL - Polonia 49
PH - Filippine 48
PK - Pakistan 46
KR - Corea 44
EC - Ecuador 41
CH - Svizzera 40
CZ - Repubblica Ceca 38
CO - Colombia 35
TH - Thailandia 35
ID - Indonesia 33
UZ - Uzbekistan 31
VE - Venezuela 29
MA - Marocco 21
CI - Costa d'Avorio 20
CL - Cile 20
LT - Lituania 20
EG - Egitto 19
IR - Iran 19
SA - Arabia Saudita 19
MY - Malesia 18
KE - Kenya 17
JO - Giordania 16
TW - Taiwan 16
DK - Danimarca 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
KZ - Kazakistan 14
PE - Perù 14
AZ - Azerbaigian 13
IL - Israele 13
PY - Paraguay 13
RO - Romania 12
HN - Honduras 11
UY - Uruguay 10
JM - Giamaica 9
NP - Nepal 9
OM - Oman 9
AU - Australia 8
GR - Grecia 8
BG - Bulgaria 7
CR - Costa Rica 7
AL - Albania 6
BO - Bolivia 6
DZ - Algeria 6
GT - Guatemala 6
LB - Libano 6
PT - Portogallo 6
SI - Slovenia 6
SN - Senegal 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
EU - Europa 5
RS - Serbia 5
SV - El Salvador 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BY - Bielorussia 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
LU - Lussemburgo 4
LV - Lettonia 4
NG - Nigeria 4
PA - Panama 4
BN - Brunei Darussalam 3
GE - Georgia 3
HR - Croazia 3
KH - Cambogia 3
MD - Moldavia 3
NI - Nicaragua 3
AM - Armenia 2
BB - Barbados 2
Totale 34.320
Città #
Singapore 1.635
Ashburn 1.260
Chandler 1.199
Dublin 1.071
San Jose 1.052
Beijing 712
Hong Kong 696
Santa Clara 613
Dallas 519
Milan 467
Ho Chi Minh City 396
Rome 385
Council Bluffs 352
Ann Arbor 351
New York 350
Boardman 337
Dearborn 326
Johannesburg 325
Hanoi 309
Parma 295
Izmir 253
Nanjing 253
Los Angeles 215
Jacksonville 211
Lauterbourg 207
Princeton 205
Shanghai 181
Munich 138
Bologna 127
Wilmington 120
Naples 115
Chicago 104
Hefei 104
Helsinki 100
Buffalo 97
San Mateo 95
Jinan 92
Seattle 89
Turin 84
Shenyang 79
São Paulo 79
Kunming 76
Bremen 75
Columbus 75
Nanchang 66
Vienna 64
Guangzhou 62
Florence 59
Hebei 58
Catania 54
Brussels 53
Toronto 52
Haiphong 51
Moscow 50
Genoa 48
Bari 47
Des Moines 46
Palermo 46
Da Nang 45
Houston 44
Jiaxing 44
Frankfurt am Main 43
Padova 43
London 41
Tianjin 41
Rio Saliceto 40
Napoli 39
Changsha 37
Tokyo 37
The Dalles 36
Modena 35
Seoul 34
Turku 34
Brescia 33
Chennai 33
Warsaw 33
Fremont 32
Orem 31
Perugia 31
Brooklyn 29
Genova 29
Atlanta 28
Belo Horizonte 28
Tashkent 28
Nuremberg 27
Reggio Emilia 27
Woodbridge 27
Rio de Janeiro 26
Düsseldorf 25
Norwalk 25
Zhengzhou 25
Amsterdam 24
Denver 24
Pisa 23
Baghdad 22
Hải Dương 22
Mexico City 22
Monza 22
Phoenix 22
Verona 22
Totale 17.893
Nome #
EVOLUZIONE ATIPICA DI UN CASO DI LEIOMIOMA METASTATIZZANTE BENIGNO POLMONARE 2.547
TUMORE FIBROSO SOLITARIO MALIGNO DELLA PLEURA ASSOCIATO A SEVERA IPOGLICEMIA: LA SINDROME DI DOEGE-POTTER 1.925
Aerostasi in chirurgia toracica nell’Azienda Ospedaliero-Universitaria di Parma: introduzione nella pratica clinica del Tachosil, un sigillante registrato come farmaco 1.143
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 660
Diverticolo tracheale acquisito: una rara causa di emottisi 473
LIPOSARCOMA DEDIFERRENZIATO MEDIASTINICO GIGANTE: UN RISCONTRO ESTREMAMENTE RARO 350
LINFOCITI INFILTRANTI IL TUMORE, BAP-1, VEGFR-2 E IGF-1R NEL MESOTELIOMA PLEURICO MALIGNO 268
A comparison between the effects of over-expression of miRNA-16 and miRNA-34a on cell cycle progression of mesothelioma cell lines and on their cisplatin sensitivity 267
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 249
Hydrogen sulfide inhibits tmprss2 in human airway epithelial cells: Implications for sars‐cov‐2 infection 246
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 239
Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 239
Fistola tracheo-esofagea congenita di tipo “H” nell’adulto 228
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 215
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 213
Adenocarcinoma associato a melanoma amelanotico primario dell’esofago distale 209
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 206
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors 205
227P Sexual dimorphism in immune profile of early and advanced NSCLC 204
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 196
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 196
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 194
Solid-phase microextraction coupled to gas chromatography mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues 194
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 185
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 183
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 183
Leiomioma metastatizzante benigno gigante 182
Delaying surgery for patients with a previous SARS-CoV-2 infection 182
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 179
Antitumoral effect of a nanotechnology-based photodynamic therapy. 178
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 176
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 176
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 175
Intraoperative Endobronchial swab after major lung resection: does it influence the course of postoperative pulmonary infections ? 173
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 172
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 170
Lung metastasis resection of adenoid cystic carcinoma of salivary glands 169
CARCINOMA NEUROENDOCRINO PRIMITIVO DEL MEDIASTINO 169
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 168
The role of miRNA-221 and miRNA-126 in patients with benign metastasizing leiomyoma of the lung: an overview with new interesting scenarios 166
Neoplasie del polmone in Neoplasie del Distretto Toracico 166
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 165
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 165
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 164
Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study 161
Linezolid-induced black hairy tongue 161
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study) 161
Isolation and characterization of human lung lymphatic endothelial cells 161
Cardiac autonomic and cortisol stress responses to real operations in surgeons: relationship with individual psychobiological characteristics and experience 159
IASLC and WHO 2004 Grading System as Prognostic Factors in 492 Cases of Pulmonary Adenocarcinoma 158
Prognostic value of [18F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience 157
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 156
A prospective, randomized, blinded comparison between continuous thoracic paravertebral and epidural infusion of 0.2% ropivacaine after lung resection surgery 156
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 155
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 155
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 154
Lipoma endobronchiale: una rara causa di ostruzione bronchiale 154
MEDIASTINITE FIBROSANTE ASSOCIATA A GRNULOMATOSI DI WEGENER 153
Posterior mediastinal myelolipoma resected by video-assisted thoracic surgery 153
Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids 152
Conversion due to vascular injury during video-assisted thoracic surgery lobectomy: A multicentre retrospective analysis from the Italian video-assisted thoracic surgery group registry 150
Multiple primary malignancies involving lung cancer: a single-center experience 150
Predictive factors of diagnostic accuracy of CT-guided transthoracic fine-needle aspiration for solid noncalcified, subsolid and mixed pulmonary nodules. 149
INTRAPLEURAL POLYMERIC FILMS CONTAINING CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA: PRELIMINARY PHARMACOKINETIC DATA IN AN OVINE MODEL 149
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 148
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 148
Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: A European Society of Thoracic Surgeons Thymic Working Group Study 148
A novel method of tracheoesophageal fistula closure 147
Physico-chemical characterization and biological evaluation of two fibroin materials 147
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 147
Multicenter experience of resected thymic epithelial tumors (TETs): an observational report on behalf of FONICAP (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone) 146
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 145
Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: Results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database 144
The Overweight Paradox: Impact of Body Mass Index on Patients Undergoing VATS Lobectomy or Segmentectomy 142
A huge ulcerated mass of the thorax 142
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 140
Longitudinal evolution of incidentally detected solitary pure ground-glass nodules on ct: Relation to clinical metrics 139
Abdominal visceral hernia through a chest wall defect secondary to open-window thoracostomy 139
Exercise capacity assessment in patients undergoing lung resection 139
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 139
The value of lung metastases resection from adenoid cystic carcinoma 138
Long-lasting tuberculous pleurisy 138
Cardiac tanponade in patient vith thoraco-abdominal aortic aneurysm 137
EXCEPTIONAL EVOLUTION OF BENIGN METASTASIZING LEIOMYOMAS OF THE LUNG 137
microRNAs Expression in Malignant Pleural Mesothelioma, Asbestosis and Benign Pulmonary Disease 137
Metaplastic carcinoma spindle-cell type of the breast 136
Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer 136
Chirurgia per carcinoma mammario con modalità day- o one-day surgery: un’esperienza di 12 anni 136
Accuracy of 18F-FDG in Detecting Stage I Lung Adenocarcinomas According to IASLC/ATS/ERS Classification 135
Metastasectomia polmonare secondaria a tumore renale (RCC). Esperienza di Parma 134
YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis. 134
Giant intercostal nerve schwannoma in a patient with neurofibromatosis type 2 134
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 133
Ground glass nodules evolution according with an history of tumour 133
An unusual case of thoracic calcifyng fibrous pseudotumor 133
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 133
Primary Pulmonary Large Cell Carcinoma with Syncytiotrophoblastic Aspect: Report of a Case 132
Thoracoscopic parietal pleural argon beam coagulation versus pleural abrasion in the treatment of primary spontaneous pneumothorax. 131
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 130
METACHRONOUS AND SYNCHRONOUS OCCURRENCE OF PRIMARY MALIGNANCIES IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE OBSERVATIONAL STUDY 130
Totale 22.603
Categoria #
all - tutte 110.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.351 0 72 92 104 51 60 158 132 91 114 63 414
2022/20234.819 422 518 282 366 375 554 142 351 1.367 70 264 108
2023/20242.534 179 223 101 94 198 471 195 195 148 175 195 360
2024/20255.736 177 344 400 302 579 554 274 249 798 532 543 984
2025/202611.816 1.119 974 1.354 944 1.581 655 1.264 488 1.419 844 650 524
2026/2027870 349 521 0 0 0 0 0 0 0 0 0 0
Totale 34.697